The Stevanato Group has announced that it will manufacture pre-fillable glass syringes for Recipharm's Resyca pre-filled syringe soft mist inhalers for the delivery of biologics. According to Stevanato Group, the interior of the Alba glass syringe has a silicone oil-based coating for improved particle release. The Resyca SMI is the product of a 2020 joint … [Read more...] about Stevanato Group to supply syringes for Recipharm’s Resyca syringe-based SMIs
Products and Services
Lonza Small Molecules adds powder characterization capabilities at Florida facility
The Lonza Small Molecules facility in Tampa, FL, USA has upgraded its powder analysis capabilities, the company said. In May 2022, Lonza announced that it was expanding its dry powder testing facilities in Tampa in order to increase its DPI development capacity. According to Lonza, the Tampa site recently added a Freeman Technologies FT4 universal powder flow … [Read more...] about Lonza Small Molecules adds powder characterization capabilities at Florida facility
Nemera and Nelson Labs announce expanded partnership
Device maker Nemera and Nelson Labs have announced the expansion of an existing partnership, with Nelson Labs performing microbiological and chemical analyses, extractables and leachables testing, and biocompatibility studies for Nemera customers. Nemera is an associate member of the International Pharmaceutical Aerosol Consortium on Regulation & Science … [Read more...] about Nemera and Nelson Labs announce expanded partnership
Copley Scientific launches DUSA Shaker DTS 100i
Copley Scientific has announced the launch of its next generation DUSA Shaker, a semi-automated tool for rinsing dose uniformity sampling apparatus (DUSA) collection tubes. According to the company, the the new DTS 100i is a "comprehensively re-engineered and updated" version of the original DUSA Shaker that "provides full, fast, repeatable rinsing" and can be used … [Read more...] about Copley Scientific launches DUSA Shaker DTS 100i
Aptar Pharma launches APF Futurity metal-free nasal spray pump for OTC products
Aptar Pharma announced that it has launched a metal-free multidose nasal spray pump called APF Futurity for delivery of over-the-counter formulations. According to Aptar Pharma, APF Futurity is designed to be recyclable without removing the pump from a container bottle and has received Class AA certification from cyclos-HT. Aptar Product Sustainability Director … [Read more...] about Aptar Pharma launches APF Futurity metal-free nasal spray pump for OTC products
Berry to open new manufacturing facility in Bangalore, India
Device manufacturer Berry Global says that it intends to hire 500 employees over 8 years to staff its new manufacturing facility in Bangalore, India, which will produce a variety of products, including nasal and inhaled drug delivery devices. The company had announced plans for the site in August 2021. Berry says that the Bangalore site has received International … [Read more...] about Berry to open new manufacturing facility in Bangalore, India
Vero Biotech closes $30 million financing to support commercialization of Genosyl tankless iNO system
Vero Biotech announced an investment of $30 million from Petrichor Healthcare Capital Management that will be used for commercialization of Vero's Genosyl DS tankless inhaled nitric oxide system. The company recently announced that it had received FDA approval for the third generation Genosyl DS for delivery of iNO to increase oxygenation in newborn infants with … [Read more...] about Vero Biotech closes $30 million financing to support commercialization of Genosyl tankless iNO system
Acorda Therapeutics announces new supply agreement with Catalent for manufacture of Inbrija inhaled dry powder levodopa
Acorda Therapeutics announced that it has signed a new supply agreement with Catalent that reduces the amount of product that the company is required to buy annually from $18 million to $8.5 million for 2023 and $15.5 million for 2024. From 2025 on, the announcement says, Acorda will pay a fixed amount per capsule "based on the amount of Inbrija needed in the US and … [Read more...] about Acorda Therapeutics announces new supply agreement with Catalent for manufacture of Inbrija inhaled dry powder levodopa
Formulated Solutions to expand its aerosol manufacturing capacity with acquisition of Tennessee facility
Florida-based CDMO Formulated Solutions announced that it has acquired a 455,000 sq ft production facility in Cleveland, TN, USA that includes two buildings fitted with pharmaceutical production and packaging lines for a variety of dose forms such as liquids, bag-on-valve aerosols, and nasal sprays. The Tennessee facility was most recently owned by German skincare … [Read more...] about Formulated Solutions to expand its aerosol manufacturing capacity with acquisition of Tennessee facility
Third Pole gets $32 million to support development of eNOcare inhaled nitric oxide device
Inhaled nitric oxide (iNO) delivery device developer Third Pole Therapeutics announced that it has received a $32 million equity investment "from a large medical device innovator." In February 2022, the company announced the closing of a $25 million financing. Chiesi acquired global rights to develop and commercialize Third Pole's tankless iNO technology in April … [Read more...] about Third Pole gets $32 million to support development of eNOcare inhaled nitric oxide device